Scripps Research Institute Scientists Develop New Technique to Selectively Dampen Harmful Immune Responses The Findings Could Lead to Treatments to Help Hemophiliacs and Other Patients
LA JOLLA, CA June 3, 2013 The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have major drawbacks, but a team from The Scripps Research Institute (TSRI) has demonstrated a new technique that may lead to a better way to selectively repress unwanted immune reactions without disabling the immune system as a whole.
As a proof of principle, the study, reported online ahead of print on June 3, 2013, by the Journal of Clinical Investigation, focused on a problem faced by some hemophiliacs rejection of a therapeutic replacement blood clotting protein.
One of the most common forms of hemophilia, hemophilia A afflicts patients who don't have enough of a critical blood clotting protein called Factor VIII. This deficiency can lead to potentially fatal, uncontrolled bleeding. Patients can take replacement Factor VIII as a biotherapeutic, but for about 20-30 percent of them, this is ineffective because their own immune systems attack the Factor VIII.
Current methods to thwart these unwanted immune attacks have severe drawbacks. One method aimed at reversing rejection of Factor VIII has been to give patients very large doses of the protein. But the treatment takes years and is prohibitively expensive. Other techniques, often used for transplant and autoimmune patients, involve taking drugs that broadly compromise the immune system.
In contrast, the new technique from TSRI selectively disables immune cells responsible for Factor VIII rejection, while leaving the rest of the immune system intact.
Harnessing B-Cells
In developing the new method, the scientists, led by James Paulson, chair of TSRI's Department of Cell and Molecular Biology, exploited their knowledge of specialized cells of the immune system.
Both wanted and unwanted immune responses revolve around a few key components. An antigen anything that the immune system detects as a problem prompts the body to produce antibodies that will neutralize and destroy the antigen. B-cells, a type of white blood cell, are the source of these antibodies after coming in contact with specific antigens. The body has millions upon millions of different types of B-cells, each recognizing different antigens.
In addition to their role as antibody producers, B-cells also have receptors on their surfaces that recognize certain naturally occurring molecules that, when bound to the B-cells, initiate their destruction. This process, known as apoptosis, is part of a complex balancing act that allows the immune system to get rid of unneeded cells.
It's this mechanism of cell death that the team is putting to use. The researchers had been working with a specific glycan (type of sugar) that binds to a key B-cell receptor, called CD22, involved in suppressing B-cell activation and apoptosis. An earlier study in collaboration with Professor David Nemazee at TSRI showed potential for causing apoptosis of B-cells with a conjugate of the glycan to small molecule antigens (haptens), but the method had not been applied to protein antigens.
After we started, we realized the opportunity to exploit the receptor's natural function in ways that might be medically relevant, said Paulson.
Preventing Misguided Attacks
To explore the idea, the Paulson group worked with mice genetically altered to lack Factor VIII, which serve as a good model for hemophilia A.
Matthew Macauley, a senior research associate in Paulson's group, and colleagues treated the animals with tiny nanoparticles that included both Factor VIII and the glycan that binds with CD22. They found this combination selectively induce apoptosis in the B-cells that recognize Factor VIII. In this way, mice that had become tolerized to Factor VIII could be successfully treated with therapeutic Factor VIII to prevent bleeding.
By eliminating only these troublesome B-cells while leaving the vast majority of the B-cells intact, the researchers were able to prevent Factor VIII rejection without any negative side effects to the immune system.
We're just taking advantage of a natural mechanism, said Macauley.
The team also conducted experiments that showed the technique prevented an unwanted immune response in mice for several months and may, under some circumstances, even lead to permanent tolerance. This would be a huge benefit if the technique can eventually be applied to humans.
One promising aspect of the new method is that the scaffold used to deliver the necessary components, called liposomal nanoparticles, is already approved by the Federal Drug Administration for other uses. This means that eventual human testing could be vastly simplified. Several pharmaceutical companies have already expressed interest in the technique.
Future Research
In future studies, Paulson, Macauley and colleagues hope to extend the work, answering questions such as: Can the technique be adapted for use on individuals who have already been exposed to Factor VIII and whose memory B-cells have become involved in rejecting the drug? Can the researchers induce tolerance to the multiple antigens on transplanted organs that can lead to organ rejection? Is the technique applicable to more complicated conditions such as allergies and autoimmune diseases such as multiple sclerosis?
We know that the issues are more complex, said Paulson, But our technique, in combination with others, might work to address them.
In addition to Paulson and Macauley, authors on the paper, titled CD22 induced B-cell tolerance prevents inhibitory antibodies to FVIII, are Fabian P
Most recent headlines
06/10/2025
France T l visions, France's leading broadcaster, has received the 2025 EBU ...
04/09/2025
Monumental Sports & Entertainment (MSE), in collaboration with Dalet, has been a...
07/08/2025
July 8 2025, 22:30 (PDT) Tata Motors & Dolby Bring Dolby Atmos to Harrier.ev, R...
17/07/2025
Early Thursday morning, the U.S. Senate voted to cut federal funding for PBS and NPR in a bill that also included cuts for foreign aid. In a 51-48 vote, the act...
17/07/2025
GREAT Britain and Northern Ireland Pavilions across IBC2025 (12 15 September, RAI Amsterdam) feature a remarkable 34 companies, each providing unique, innovativ...
17/07/2025
WHITE PLAINS, N.Y. The Society of Motion Picture and Television Engineers today introduced its Content Provenance and Authenticity (CPA) in Media Study Group (S...
17/07/2025
NEW YORK Despite widespread concerns about a soft advertising market, NBCUniversal said it closed its 2025-26 upfront negotiation cycle with a record ad sales v...
17/07/2025
NEW YORK Television advertising remains an effective means to market and influence younger baby boomer and Generation X consumers approaching retirement age, ac...
17/07/2025
ALLENTOWN, Pa. & JERSEY CITY, N.J. Service Electric Cable TV and OpenVault have announced that the operator is deploying the OpenVault Proactive Network Manage...
17/07/2025
WASHINGTON Following up on his first major policy speech just two ago, Federal Communications Commission Chair Brendan Carr is promising to buck the usual summ...
17/07/2025
Luxembourg, 14 July 2025 - SES received the final regulatory approvals for the SES-Intelsat transaction, including the US Federal Communications Commission.
O...
17/07/2025
Berklee Alumni Nominated for 2025 Emmy Awards Twenty-three Berklee alumni received nominations across categories in sound mixing, sound editing, and compositi...
16/07/2025
It's Emmy nominations day, and Sundance Institute storytellers are basking i...
16/07/2025
Spotify's podcast editorial team is always on the hunt for shows and episodes that spark conversation, push boundaries, and keep us coming back for more. As...
16/07/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({...
16/07/2025
Join us at IBC this September and take control of your content. Discover how we're bringing a new level of purpose and precision to the application of AI in...
16/07/2025
Warsaw - Poland, June 24, 2025 - Nielsen, the global leader in audience measurement, data and analytics, has released its latest May All Screens Video Landscape...
16/07/2025
Bluey Tops Nielsen's Overall Streaming List with More Than 25 Billion Minutes Streamed from January through June 2025
Big June Vaults Squid Game into Top O...
16/07/2025
TV SIM, the SBT affiliate serving Esp rito Santo state in Brazil, has launched a transmitter upgrade initiative with the installation of a Rohde & Schwarz R&S T...
16/07/2025
Pebble, the leading automation, content management and integrated channel specialist, is turning its vision to the future of automation with its demonstrations ...
16/07/2025
Ikegami announces a new addition to its UNICAM-XE product range with the introduction of the UHK-X700RF wireless portable camera: The new version has the same f...
16/07/2025
Today, Amazon Web Services added TwelveLabs as a new model provider to Amazon Bedrock, delivering what could be the most significant breakthrough in enterprise ...
16/07/2025
NEW YORK Streaming platforms continued to dominate TV viewing patterns in June, with data from Nielsen's 50th monthly report of The Gauge showing that strea...
16/07/2025
MAHWAH, NJ Ikegami has introduced the the UHK-X700RF wireless portable camera, a new addition to its UNICAM-XE product range with the same feature set, operatio...
16/07/2025
LONDON IBC2025 organizers said global attendees will have access to a new feature that will integrate Amsterdam's GVB public transport pass into the officia...
16/07/2025
July 16th, 2025
Tribeca Films to Release the Acclaimed LARPing Doc WE CAN BE HEROES by Carina Mia Wong and Alex Simmons, Alongside a Slate of Festival-Favori...
16/07/2025
Deltatre Acquires Endeavor Streaming in Major Streaming Industry Move The transaction is expected to close in the third quarter of 2025 By Brandon Costa, Direc...
16/07/2025
SVG Regional Sports Production Summit 2025: All Sessions Now Available to Watch ...
16/07/2025
Wednesday 16 July 2025
Sky and ITV today announced an extension of their long-standing partnership, which will see ITV's content and services remain seamle...
16/07/2025
Sky Sports lifts the lid on Lions life with hilarious behind-the-scenes mockumentaryWednesday 16 July 2025
To view this content, please enable our use of cooki...
16/07/2025
CULVER CITY, CALIFORNIA Apple TV+ today earned a record-breaking 81 Emmy Award nominations across 14 hit Apple Original titles for this year's 77th Emmy Awa...
15/07/2025
Independent media outlets in Brazil and Colombia are invited to apply for a new programme aimed at strengthening the long-term resilience of journalism in the f...
15/07/2025
By Lucy Spicer
One of the most exciting things about the Sundance Film Festival...
15/07/2025
Spotify une fuerzas con DiDi, la app l der en servicios de movilidad, delivery y...
15/07/2025
The National Film and Video Foundation (NFVF), an agency of the Department of Sp...
15/07/2025
L3Harris put its CORVUS-RAVEN counter-small UAS capability into the hands of soldiers at VANAHEIM, showcasing its ability to provide passive signal detect, enha...
15/07/2025
Netflix Viewing Up 13.5% vs. May, Represents 42% of Monthly Gain for Streaming
...
15/07/2025
SAN FRANCISCO and BENGALARU, India Sangeeta Chakraborty has been named chief revenue officer at Amagi, a cloud-based software-as-a-service (SaaS) technology pro...
15/07/2025
As part of its mandate, the Advanced Television Systems Committee the U.S. organization tasked with developing advanced broadcast TV standards promotes ATSC 3.0...
15/07/2025
QuickLink, the leading global provider of multi-camera video productions and remote contributions, announces the launch of two innovative control panels Studi...
15/07/2025
Chris Kontopanos has joined leading high-quality microphone solutions manufacturer, DPA Microphones, as the company's new Regional Sales Manager for the Mid...
15/07/2025
Magnifi by VideoVerse, a global leader in AI-powered video automation, has launched a major platform upgrade built to simplify live and archival video editing f...
15/07/2025
Telestream, a global leader in media workflow technologies, will preview its latest innovations at IBC2025, Stand 7.B21. This year's showcase highlights how...
15/07/2025
IBC2025 is set to transform the onsite experience for its global attendees with the launch of a pioneering new feature: full integration of Amsterdam's GVB ...
15/07/2025
Music, sport and technology collided in spectacular fashion as ASB GlassFloor powered the debut of Beats N Buckets, Germany's first Basketball meets Hip-Ho...
15/07/2025
The Collectv, the Emmy award-winning broadcast solutions and workflows consultancy - and winner of Broadcast Tech's Team of the Year is delighted to announc...
15/07/2025
SipRadius, the expert in secure, low latency media transport, will showcase how broadcasters and media companies can take control of fragmented IP workflows at ...
15/07/2025
Appear, the global leader in live production technology, today announced its strategic partnership with beIN ASIA PACIFIC, a leading multi-platform sports media...
15/07/2025
Company marks 15 years of innovation at the show
Broadpeak, a leader in streaming and monetization at scale, will return to IBC (Hall 1, Stand F83. RAI, Amster...
Scripps Research Institute Scientists Develop New Technique to Selectively Dampen Harmful Immune Responses The Findings Could Lead to Treatments to Help Hemophiliacs and Other Patients
